SPECTRA XT is the latest new cutting-edge device from Lutronic Corporation
The Spectra XT is called “The Extended Platform” because of its widely-extended clinical indications and applications as compared to previous similar devices currently on the market.
In particular, its newly extended treatments, namely “Gold Toning” with 595 nm, “RuVY Touch” with 660 nm and “Revital Treatment” with 1064 nm quasi-long pulse (Max. 45 J / sec), offer more treatment choices to both doctors and patients, without the need to invest in additional devices separately.
Both 585 nm and 595 nm are relatively effective wavelengths, but 595 nm might be slightly safer due to its lower absorption in melanin, thus minimizing potential side effects such as PIH.
660 nm is a safer wavelength than 532 nm for removal of epidermal pigmented lesions due to its lower absorption in melanin and oxy- and deoxy-hemoglobin.
In particular, the lower absorption characteristics of 660 nm in oxyand deoxy-hemoglobin allow vessels to remain intact even after laser treatment, therefore minimizing potential side effects such as PIH that usually occur as a result of inflammation.
High powered quasi-long pulsed 1064 nm capable of delivering a maximum of 45 J in a second is an effective wavelength to promote good collagen remodeling effect.